INTRODUCTION
============

Ubiquitination is an important cellular process that affects protein homeostasis; it also controls complex processes during embryogenesis ([@b21-molce-40-12-945]). Abnormal ubiquitination can result in the development of major human neurodegenerative diseases such as Parkinson's and Alzheimer's ([@b1-molce-40-12-945]). Ubiquitination involves three enzymes, ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), and ubiquitin ligase (E3), which modify proteins and affect their localization and stability ([@b14-molce-40-12-945]). Among the three enzymes, E3 ligases are critical for determining substrate specificity. E3 ligases are classified into two major subtypes based on their structural characteristics: RING domain-containing and HECT domain-containing E3 ligases ([@b15-molce-40-12-945]). Furthermore, discrete ubiquitin chains on a substrate dictate whether the protein will alter its cellular localization or undergo proteasomal degradation ([@b22-molce-40-12-945]).

As a member of the RING domain-containing E3 ligase family, RNF152 is an important regulator of proteins functioning downstream of mechanistic target of rapamycin complex 1(mTORC1) signaling ([@b5-molce-40-12-945]). In particular, mechanistic target of rapamycin (mTOR) is a serine/threonine kinase that regulates cellular growth and proliferation during the early stages of neurogenesis ([@b21-molce-40-12-945]). RNF152 targets RagA GTPase for K-63-mediated ubiquitination, which activates its inhibitor GATOR1, a GAP complex for Rag GTPase, thereby inactivating mTORC1 signaling ([@b5-molce-40-12-945]). Although mTORC1 activity is critical in neonatal neuronal stem cells in the subventricular zone during neurogenesis ([@b7-molce-40-12-945]), the biological functions of RNF152 in embryogenesis have not yet been addressed.

Thus, we conducted molecular genetic studies on Rnf152 using zebrafish embryos to define the expression patterns, biological functions, and transcriptional regulation of *rnf152*. We discovered that *rnf152* was maternally and zygotically expressed at early and late embryonic stages. Expression of *rnf152* was found in the midbrain and hindbrain boundary (MHB), rhombomeres (r1--7), and eyes at 48 hpf (hours post fertilization). In addition, overexpression and knockdown studies demonstrated that Rnf152 was involved in development of the eyes, MHB, and hindbrain. Furthermore, molecular marker studies using *neuroD, deltaD, notch1a,* and *notch3* showed that Rnf152 might be an upstream regulator of Delta-Notch signaling during embryogenesis in zebrafish. Based on these observations, we describe the functions of *rnf152* in embryogenesis.

MATERIALS AND METHODS
=====================

Rnf152 sequence analysis
------------------------

Phylogenetic analysis was performed to identify evolutionary relationship between zebrafish Rnf152 (NP_001014380) with human RNF152 (NP_775828), chimpanzee RNF152 (XP_001143948), mouse RNF152 (NP_848894), chicken RNF152 (NP_001291963), and *Xenopus* Rnf152 (XP_004915369). Neighbor-joining phylogenetic tree was generated with the online available software, MEGA7.0 (<https://www.megasoftware.net>). Information about amino acids sequence for human, chimpanzee, mouse, chicken, *Xenopus*, and zebrafish was collected from available proteins in NCBI, <https://www.ncbi.nlm.nih.gov/protein/>.

Zebrafish maintenance and embryo generation
-------------------------------------------

Wild type synchronized embryos were produced and maintained at 28.8°C ([@b29-molce-40-12-945]). Embryos were collected with natural breeding in the cycle of 10-hour dark/14-hour light and morphological confirmation was done as described in [@b11-molce-40-12-945]. Embryos were treated with 0.2 mM Phenylthiourea (PTU) after 9 hpf to stop melanogenesis.

RNA preparation, cDNA synthesis, and RT-PCR
-------------------------------------------

Total RNA was isolated from various stages of zebrafish embryos using R&A-BLUE® Total RNA Extraction kit (iNtRON Biotechnology) and cDNA was synthesized with M-MLV Reverse Transcriptase (Enzynomics) with Oligo (dT)~20~ primer. The primers were used for PCR to analyze the zebrafish *rnf152* specific template (235 bp) in different stages of embryos, forward primer; TCTCCCATCTCCCAGATG and reverse primer; AGACCGTCATGTCCTAGA, for *β-actin* (500 bp), as an internal control for this experiment, Forward Primer; GAGGAGCACCCCGTCCTGC and Reverse Primer; GATGGCT GGAACAGGGCC. After the completion of PCR reaction, every set of reaction was confirmed with running 1% agarose gel in TE buffer using gel electrophoresis and sent for sequencing to SolGent Co. Ltd after cloning in pGEMT-easy vector. The protocols were established and applied as previously in our laboratory ([@b2-molce-40-12-945]).

Whole-mount *in situ* hybridization (WISH)
------------------------------------------

After sequence confirmation, cloned *rnf152* construct was linearized with restriction enzyme and anti-sense DIG-labeled probe was synthesized with T7 RNA polymerase and sense probe was also synthesized as well to provide WISH in a negative manner, protocol was adapted from the Roche instructions. Embryos were fixed in 4% paraformaldehyde (PFA) overnight. Embryos over 24 hpf were treated with proteinase K. WISH was performed as described in ([@b25-molce-40-12-945]) with minor laboratory modification. Two color WISH was performed as previously done in the laboratory ([@b2-molce-40-12-945]). Images were captured when embryos were in 90% glycerol in PBST solution with Leica MZ16.

Overexpression of *rnf152* mRNA
-------------------------------

We selected a positive strand of *rnf152* ORF (675bp) and primers were designed as; Forward Primer; CGGAATTCATGT GCAACAGCCACGATTT, Reverse Primer; GCCTCGAGTCCAC AGGAAATAATAGTGA. After amplification, cloning was performed in pcGlobin2 vector ([@b20-molce-40-12-945]). After confirming the sequence, the construct was linearized and applied for the synthesis of *rnf152* capped mRNA with mMessage mMachine® High Yield Capped RNA Transcription Kit (Ambion® Applied Biosystems) and purified capped mRNA was injected (200 pg) in 1- or 2- cell stage of zebrafish embryos, phenol red dye with distilled water was injected as vehicle control in similar volume. Phenotypes were observed in every 6 hours and images were captured at 24 hpf.

Knock-down analysis
-------------------

As we identified that zebrafish pre-mRNA has only a single exon, so a splice modifying Morpholino was not a possibility and we designed a translational blocking Morpholino; GCTC TGGGACAAGCTATCCATCGTC. For a specificity control, we designed 5′ mismatch oligo; GCTgTcGGAgAAcCTATCCATCcTC. We collected *rnf152* Morpholino and its 5′ mismatch control from [www.gene-tool.com](www.gene-tool.com). commercially available oligoes. Injected in synchronized 1- or 2-cell zebrafish embryos and incubated in E3 medium at 28.8°C incubator, we investigated phenotype after every 3 h. Methods for morpholino injection were adopted from previously done in laboratory ([@b33-molce-40-12-945]).

RESULTS
=======

Zebrafish Rnf152 is an orthologue of human RNF152
-------------------------------------------------

The neighbor-joining phylogenetic relationships between the amino acid sequence of zebrafish Rnf152 and those of homologues from other species were analyzed using Phylogenetic and Molecular Evolutionary Analysis MEGA software package (version 7.0) ([@b12-molce-40-12-945]). Rnf152 (NP_001014380) comprised 198 amino acid residues. The chimpanzee, mouse, chicken, and *Xenopus* RNF152 clade shared a common ancestor with zebrafish Rnf152 ([Fig. 1A](#f1-molce-40-12-945){ref-type="fig"}). Zebrafish Rnf152 was 57.6% homologous with human RNF152, and 55% homologous with chimpanzee, mouse, chicken, and *Xenopus* RNF152 ([Supplementary Fig. S1](#s1-molce-40-12-945){ref-type="supplementary-material"}). Zebrafish *rnf152* was located on linkage group (LG) 2 within NC_007113.7 ([www.ncbi.nlm.nih.gov](www.ncbi.nlm.nih.gov)). Based on the phylogenic relationship between zebrafish Rnf152 and human RNF152, molecular and functional analysis of zebrafish Rnf152 during early embryogenesis might provide important insights on the physiological function of human RNF152.

*rnf152* transcripts are expressed in the eyes, MHB, and rhombomeres (r1--7) at 48 hpf
--------------------------------------------------------------------------------------

The temporal expression pattern of *rnf152* during embryonic development was examined using RT-PCR. The *rnf152* transcript was detected at the 1-cell stage, and its expression persisted until 48 hpf ([Fig. 1B](#f1-molce-40-12-945){ref-type="fig"}), indicating that it was expressed both maternally and zygotically. To further define the spatiotemporal expression pattern of *rnf152*, whole-mount *in situ* hybridization (WISH), which employed an *rnf152*-specific antisense RNA probe, was performed using zebrafish embryos at various developmental stages. The maternal transcript was ubiquitously distributed from the 1-cell stage to the gastrula stage ([Figs. 2A and 2D](#f2-molce-40-12-945){ref-type="fig"}), where it uniformly localized along the anteroposterior axis until mid-somitogenesis ([Figs. 2E and 2F](#f2-molce-40-12-945){ref-type="fig"}). Although *rnf152* expression was restricted to the diencephalon and spinal cord at 18 hpf ([Figs. 2G and 2H](#f2-molce-40-12-945){ref-type="fig"}), it localized to the developing eyes, forebrain, midbrain, hindbrain, and presomitic mesoderm of posterior somites at 24 hpf ([Figs. 2I and 2K](#f2-molce-40-12-945){ref-type="fig"}). At 48 hpf, *rnf152* expression was exclusively detected in the retina, midbrain-hindbrain boundary (MHB), and rhombomeres (r1--7) ([Figs. 2L and 2N](#f2-molce-40-12-945){ref-type="fig"}), indicating that *rnf152* might be required for proper development of specific regions in the brain during embryogenesis.

*rnf152* is required for proper development of the eyes, MHB, and rhombomeres (r1--7) during embryogenesis
----------------------------------------------------------------------------------------------------------

To examine the biological functions of Rnf152, its expression was forced by microinjecting the *rnf152* transcript into zebrafish embryos at the 1- to 2-cell stage. Although there were no significant morphological defects until 24 hpf, we found three major changes in Rnf152-overexpressing embryos ([Fig. 3C](#f3-molce-40-12-945){ref-type="fig"}): an indistinctive midbrain-hindbrain boundary (MHB), a diminished hindbrain (r1--7), and a smaller eye compared with vehicle control and WT embryos ([Figs. 3A and 3B](#f3-molce-40-12-945){ref-type="fig"}). The graph depicts the diameter of the eye ([Fig. 3G](#f3-molce-40-12-945){ref-type="fig"}) and the width of the neural tube in *rnf152* overexpressing, vehicle control, and WT embryos ([Fig. 3H](#f3-molce-40-12-945){ref-type="fig"}). Furthermore, we knocked down *rnf152* with gene-specific morpholino antisense oligonucleotides and observed that the diameter of the eye was significantly smaller, whereas the MHB was undistinguishable and rhombomeres (r1--7) were smaller ([Fig. 3F](#f3-molce-40-12-945){ref-type="fig"}), than comparable structures in 5′ mismatch control ([Fig. 3E](#f3-molce-40-12-945){ref-type="fig"}) and WT ([Fig. 3D](#f3-molce-40-12-945){ref-type="fig"}) embryos at 24 hpf. We also measured the diameter of the eye (I) and the width of the neural tube (J) in knocked down embryos and compared these parameters with those in 5′ mismatch control and WT embryos, confirming that both the overexpression and knockdown of *rnf152* significantly reduced the size of the eyes and the width of the neural tube ([Figs. 3C and 3F](#f3-molce-40-12-945){ref-type="fig"}). These results indicate that Rnf152 is required for the proper development of the eyes and neural tube.

*neuroD* expression pattern was significantly altered in the eyes and brain of *rnf152* morphants
-------------------------------------------------------------------------------------------------

To identify the molecular elements in developing tissues affected by knockdown of *rnf152*, we selected molecular markers for the eyes, MHB, and rhombomeres. *NeuroD* is a marker for the inner and outer layers of the eyes at 48 hpf, although its expression is also observed in the central nervous system and lateral line in zebrafish embryos ([@b26-molce-40-12-945]). *NeuroD* is crucial in mitotic cells, where it serves as an important connector of cell cycle exit and cell fate determination in zebrafish ([@b17-molce-40-12-945]). To examine whether the knockdown of *rnf152* affected any cellular events, including *neuroD* expression during development of the eyes and brain, two color WISH analysis using *neuroD*-and *pax6-*probes was performed in *rnf152*-deficient embryos at 27 hpf. Surprisingly, *neuroD* expression was significantly reduced in the telencephalon, dorsal diencephalon, eyes, ganglion, octaval/statoacustic (III) ganglion, posterior lateral line ganglion, and pancreatic bud of *rnf152*-deficient embryos at 27 hpf ([Figs. 4C and 4F](#f4-molce-40-12-945){ref-type="fig"}), but was unaffected in the indicated areas of WT ([Figs. 4A and 4D](#f4-molce-40-12-945){ref-type="fig"}) and 5′ mismatch MO control ([Figs. 4B and 4E](#f4-molce-40-12-945){ref-type="fig"}) embryos. In particular, *neuroD* expression was completely abolished from the ONL, INL, and GCL of the eyes in *rnf152*-deficient embryos at 27 hpf. On the other hand, knockdown of *rnf152* did not affect *pax6* expression in *rnf152*-deficient embryos at 27 hpf ([Figs. 4C and 4F](#f4-molce-40-12-945){ref-type="fig"}). Furthermore, WISH analysis using a *rx2*-specific probe to detect modifications in the optic vesicles of *rnf152* deficient embryos at 12, 15, and 18 hpf found no significant changes in the optic vesicles and eyes after knockdown ([Supplementary Fig. S4](#s1-molce-40-12-945){ref-type="supplementary-material"}). These results strongly support the role of Rnf152 in tissue-specific development of the eyes, midbrain, and hindbrain at developmental stages later than 18 hpf during zebrafish embryogenesis.

*deltaD* expression significantly decreased in *rnf152* morphants
-----------------------------------------------------------------

Notch-Delta signaling determines cell fate in the eyes, particularly the decision of neurons or Müller glia to differentiate or not differentiate ([@b24-molce-40-12-945]). In addition, *deltaD* and *deltaC*, as well as *notch1a* and *notch 3*, were expressed in the ciliary marginal zone in larval and juvenile zebrafish ([@b19-molce-40-12-945]). Thus, we investigated whether the expression patterns of the *delta* and *notch* genes matched that of *neuroD* found in *rnf152*-deficient embryos ([Fig. 4](#f4-molce-40-12-945){ref-type="fig"}).

We examined *deltaD* expression in *rnf152*-deficient embryos at 24 hpf. *DeltaD* expression was reduced in the eyes, forebrain, MHB, and hindbrain in *rnf152*-deficient embryos ([Figs. 5C and 5F](#f5-molce-40-12-945){ref-type="fig"}). Although *deltaD* expression was also significantly reduced in the midbrain of *rnf152-*deficient embryos ([Figs. 5C and 5F](#f5-molce-40-12-945){ref-type="fig"}), it was unaffected in WT ([Figs. 5A and 5D](#f5-molce-40-12-945){ref-type="fig"}) and 5′ mismatch control ([Figs. 5B and 5E](#f5-molce-40-12-945){ref-type="fig"}) embryos. WISH analysis further confirmed that *deltaC* expression in *rnf152* deficient embryos was elevated in the outer plexiform layer, ONL, INL, and inner plexiform layer of the eye but significantly reduced in the brain at 24 hpf ([Supplementary Figs. S2C and S2F](#s1-molce-40-12-945){ref-type="supplementary-material"}) due to the fact that *deltaC* and *deltaD* are inversely regulated in the eyes and brain of zebrafish embryos ([@b30-molce-40-12-945]). Thus, *deltaD* expression might be positively regulated by Rnf152 in the eyes and brain of the developing zebrafish embryos at 24 hpf.

Knockdown of *rnf152* decreased expression of Notch downstream genes
--------------------------------------------------------------------

We showed that *neuroD* expression decreased in the telencephalon, octaval/statoacustic (III) ganglion, posterior lateral line ganglion, and dorsal diencephalon, but was abolished in the ONL, INL, and GCL of the eyes in *rnf152*-deficient embryos at 27 hpf ([Figs. 4C and 4F](#f4-molce-40-12-945){ref-type="fig"})*. DeltaD* expression was also abolished in the eyes and brain at 24 hpf ([Figs. 5C and 5F](#f5-molce-40-12-945){ref-type="fig"}). Various members of the Notch receptor family are expressed in the zebrafish brain ([@b3-molce-40-12-945]). Notch receptors also serve as molecular switches between neurogenesis and the self-renewal of neural stem cells ([@b34-molce-40-12-945]). We initially selected three members of the Notch receptor family, *notch1a, notch1b*, and *notch3*, and examined their spatiotemporal expression patterns in *rnf152* deficient embryos at 24 hpf by WISH analysis.

Except for the telencephalon, *notch1a* expression was markedly lower in the eyes and brain of *rnf152*-deficient embryos at 24 hpf ([Figs. 6C and 6F](#f6-molce-40-12-945){ref-type="fig"}) than in WT ([Figs. 6A and 6D](#f6-molce-40-12-945){ref-type="fig"}) and 5′ mismatch control ([Figs. 6B and 6E](#f6-molce-40-12-945){ref-type="fig"}) embryos. However, there was no change in *notch1b* expression in *rnf152*-deficient embryos compared with WT and 5′ mismatch control embryos ([Supplementary Fig. S3](#s1-molce-40-12-945){ref-type="supplementary-material"}). In addition, except for the olfactory bulbs ([Figs. 6I and 6L](#f6-molce-40-12-945){ref-type="fig"}), *notch3* expression was significantly lower in the midbrain and rhombomeres (r1--7) than in the WT ([Figs. 6G and 6J](#f6-molce-40-12-945){ref-type="fig"}) and 5′ mismatch MO control ([Figs. 6H and 6K](#f6-molce-40-12-945){ref-type="fig"}) embryos. These results clearly indicate that *delta* and *notch* family genes might be downstream targets of Rnf152 in specific regions of the brain in zebrafish embryos during development.

Among the *her* genes in zebrafish ([@b28-molce-40-12-945]), *her4* mediates Notch signaling during neurogenesis ([@b23-molce-40-12-945]). Transcription of *her4* is activated by a constitutively active *notch1a* variant encoded by the Notch intracellular domain, and abnormal expression of *her4* decreases the number of *islet-1*-positive cells ([@b23-molce-40-12-945]; [@b27-molce-40-12-945]). On the other hand, a recent study reported that *neuroD* represses Notch signaling, which positively regulates transcription of *ascl1a* in photoreceptor progenitors ([@b24-molce-40-12-945]). Thus, we used WISH analysis to investigate *her4* as a downstream gene of Notch signaling to determine whether its expression pattern was affected in *rnf152*-deficient embryos. As shown in [Fig. 7C](#f7-molce-40-12-945){ref-type="fig"}, *her4* expression was hardly visible in the eyes and was significantly decreased in the MHB; however, it was abundant at these sites in control embryos ([Figs. 7A and 7B](#f7-molce-40-12-945){ref-type="fig"}). However, knockdown of *rnf152* did not affect *her4* expression in the spinal cord ([Fig. 7C](#f7-molce-40-12-945){ref-type="fig"}). On the other hand, *ascl1a* expression in the eyes and midbrain of *rnf152*-deficient embryos ([Fig. 7F](#f7-molce-40-12-945){ref-type="fig"}) was lower than that in WT and 5′ mismatch control ([Figs. 7D and 7E](#f7-molce-40-12-945){ref-type="fig"}) embryos. Thus, *rnf152* might be required for maintenance of *notch1a* expression, as well as for the proper expression of *her4* in the eyes and MHB, but dispensable in the spinal cord, where *her4* expression might be dependent upon other Notch receptors or Notch-related genes besides Notch1a and Notch3 ([@b4-molce-40-12-945]; [@b8-molce-40-12-945]; [@b9-molce-40-12-945]; [@b16-molce-40-12-945]). Taken together, these results indicate that Rnf152 regulates transcription of *ascl1a*, which is independent of *neuroD* expression.

DISCUSSION
==========

We report here that *neuroD* expression was hardly visible in the ONL, INL, and GCL of the eyes, and was reduced in the telencephalon, octaval/statoacustic (III) ganglion, posterior lateral line ganglion, and dorsal diencephalon, in *rnf152* morphants at 27 hpf ([Fig. 4](#f4-molce-40-12-945){ref-type="fig"}). A previous study demonstrated *neuroD* expression in the cranial ganglia, diencephalon, epiphysis, retina, rhombomeres, mid-hindbrain, telencephalon, and spinal cord of zebrafish embryos at 48 hpf ([@b18-molce-40-12-945]). *NeuroD* is a pro-neural bHLH transcription factor that is responsible for regeneration and genesis of photoreceptor cells via Delta-Notch signaling in zebrafish embryos at 72 hpf ([@b24-molce-40-12-945]). NeuroD negatively regulates expression of molecules downstream of Notch signaling, which affects expression of Notch targets at 72 hpf ([@b24-molce-40-12-945]). Unexpectedly, we found that Notch signaling was abolished in the absence of Rnf152, even when *neuroD* expression was severely impaired in the *rnf152* morphants. Thus, the results indicate that Rnf152 is required for expression of *neuroD* and for maintenance of Delta-Notch signaling, which might fine-tune differentiation of the anterior neural tissue, including the eyes. In addition, it is possible that knockdown of *neuroD* alone in the absence of functional Rnf152 might not be enough to de-repress Notch signaling. Identification of the molecular relationship between NeuroD and Rnf152 will unveil the role of Rnf152 in Delta-Notch signaling.

*DeltaD* is a Notch ligand expressed in differentiating neurons of the CNS and in the eyes of zebrafish embryos at 24 hpf ([@b3-molce-40-12-945]). In agreement with these observations, we found that *deltaD* expression was abundant in the eyes and CNS of WT, but markedly reduced in these tissues in *rnf152*-deficient, embryos at 24 hpf ([Figs. 5C and 5F](#f5-molce-40-12-945){ref-type="fig"}). On the other hand, *deltaC* expression was elevated in *rnf152*-deficient embryos at 24 hpf ([Supplementary Fig. S2](#s1-molce-40-12-945){ref-type="supplementary-material"}). Considering that DeltaC and DeltaD are Notch ligands in the eyes and brain, and that DeltaC counteracts DeltaD in zebrafish embryos at 16 hpf ([@b30-molce-40-12-945]), we propose that Rnf152 might be an upstream regulator of *deltaD*, and that elevated *deltaC* expression in the *rnf152* morphants might be caused by reduction of *deltaD* expression.

NeuroD2 is a transcription factor harboring a Cdc20 recognition motif and destruction box (D-box) that regulates presynaptic development in the brain ([@b31-molce-40-12-945]). The major mitotic E3 ubiquitin ligase, Cdc20-anaphase-promoting complex, activates presynaptic differentiation by promoting protein degradation, which negatively regulates presynaptic development ([@b32-molce-40-12-945]). Given that NeuroD2 expression is inversely correlated with that of Cdc20, the cellular level of NeuroD2 is regulated by the ubiquitin-proteasome system ([@b31-molce-40-12-945]).

The E3 ligase gene, Mib1, regulates neurogenesis in the developing spinal cord via Delta-Notch signaling ([@b10-molce-40-12-945]). Furthermore, expression of Notch receptor family members such as *notch1a* and *notch3* was also reduced in *rnf152*-deficient embryos at 24 hpf. Transcription of Notch downstream targets, *her4* and *ascl1a*, was also compromised by depletion of Rnf152 at 24 hpf. In this context, it is plausible that Rnf152 functions in these tissues by targeting molecules such as NeuroD, Delta, and Notch. Considering that both autosomal dominant and autosomal recessive mutations in proteins of the Notch signaling pathway cause several human disorders, including Alagille syndrome and spondylocostal dysostosis ([@b13-molce-40-12-945]), the discovery of novel Notch regulators increases our understanding of Notch signaling. We propose that Rnf152 is a novel Notch regulator, and that it might have therapeutic potential with respect to diseases caused by aberrant Notch activation.
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==================
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![(A) Phylogenetic analysis for Rnf152 in higher vertebrates\
Neighbor-joining method of MEGA7 was applied to derive the phylogenetic tree upon the amino acid sequences of human (NP_775828), chimpanzee (XP_001143948), mouse (NP_848894), chicken (NP_001291963), *Xenopus* (XP_004915369) and zebrafish (NP_001014380) which were collected from NCBI database. The scale bar denotes the branch distance in the figure. (B) RT-PCR analysis for temporal expression pattern of zebrafish *rnf152*. *rnf152* was expressed both maternally and zygotically in zebrafish embryos. *β-actin* (500bp) was served as internal control (lower panel). Early and late stages of the zebrafish embryos abundantly expressed *rnf152*. Amplicon size of *rnf152* was 235bp and equal amount of cDNA was in each reaction of all the tested stages with the endogenous control \[No. of experiments (n) =3\].](molce-40-12-945f1){#f1-molce-40-12-945}

![Spatiotemporal expression patterns of zebrafish *rnf152*\
(A--C) Lateral view; *rnf152* was abundantly expressed in the zebrafish embryos at early stages. (D) Image from the animal pole of shield stage demonstrated thin germ ring with embryonic shield (arrowhead). (E--G) Lateral view of the embryos at tail bud, 14 hpf and 18 hpf. (H) Dorsal view of the embryo at 18 hpf found *rnf152* transcripts in the eyes, CNS and spinal cord. (I&J) Lateral and (K) anterior view of the embryos at 24 hpf showed *rnf152* transcripts were present in the eyes and CNS and some parts of posterior region. (L&M) Lateral view, (N) dorsal view of the embryos at 48 hpf demonstrated that *rnf152* transcripts were in the eyes, midbrain and hindbrain boundary (MHB), and rhombomeres. All embryos were collected synchronously from WT zebrafish for WISH analysis at the corresponding stages. Abbreviations: de- Diencephalon, ES- Embryonic shield, Fb-Forebrain, hb-hind brain, PSM- presomitic mesoderm, ret-eye, SC- spinal cord (n=3). Scale bars A-N: 50 μm.](molce-40-12-945f2){#f2-molce-40-12-945}

![Overexpression and knockdown of *rnf152* in zebrafish embryos\
(A) WT zebrafish embryo, (B) vehicle control injected with the same volume of phenol red dye in distilled water as the volume of the mRNAs injected, and (C) *rnf152* mRNA injected embryo. Microinjection of *rnf152* mRNA (200 pg) into embryos at 1- or 2 cell stages for overexpression of *rnf152*. All images are in lateral view (n = 3). (D) WT, (E) 5′ mismatch MO, and (F) *rnf152* MO that 5 ng of *rnf152* morpholino was injected into embryos at 1-cell stage for knockdown of *rnf152.* All images (D--F) are in lateral view of embryos at 24 hpf. (G--J) Graphs showing diameter of the eyes and width of the neural tubes. (G) Diameter of the eyes, (H) width of the neural tube of WT, vehicle control, and *rnf152* overexpressed embryos. (I) Diameter of the eyes, (J) width of the neural tube of WT, 5′ mismatch control, and *rnf152* MO. Red arrowheads indicate the rhombomeres (r1--7) while dotted red lines indicate the width of the neural tube. Area of the eyes was marked with red dotted lines. The graphs were obtained using ImageJ, error bars depicting standard errors. Unpaired t-test was executed to obtained p-values, which is p\<0.0001 (n=3). Abbreviations: fb- forebrain, hb- hindbrain, mb- midbrain, NT- neural tube, ret- eye, SC- spinal cord, and TB- tail bud. Scale bars A--F: 50 μm.](molce-40-12-945f3){#f3-molce-40-12-945}

![Knock-down of *rnf152* decreased the level of *neuroD* in the telencephalon, dorsal diencephalon, eyes, octaval/statoacustic ganglia, and posterior lateral line ganglia\
Two color WISH analysis with *neuroD-* and *pax6*--specific probes detected changes in their transcripts in the retinal layers of embryos at 27 hpf. (A, D) WT, (B, E) 5′ mismatch MO control, and (C, F) *rnf152* MO. *neuroD* transcripts (dark blue) were abundant in the INL and ONL of eyes, telencephalon, dorsal diencephalon, octaval/statoacustic ganglia and posterior lateral line ganglia of WT as well as the 5′ mismatch control, but remarkably reduced in *rnf152* MO. Levels of *pax6* transcripts (tomato color) in the telencephalon, dorsal diencephalon, hindbrain, anterior spinal cord, and eyes of the WT were similar those of *rnf152* MO at 27 hpf. Red arrowheads indicates the areas of significant differences in the level of *neuroD* transcripts between WT and *rnf152* MO. Abbreviations: ad/av/f- Anterodorsal/anteroventral lateral line/facial placodes/ganglia, dd- Dorsal diencephalon, GCL- Ganglion cell layer, INL- Inner nuclear layer, o- Octaval/statoacustic ganglia. ONL- outer nuclear layer, p- Posterior lateral line ganglia, RPE- retinal pigment epithelium, T- Telencephalon (n = 3). Scale bars (A--F): 50 μm.](molce-40-12-945f4){#f4-molce-40-12-945}

![Level of *deltaD* transcripts was reduced in *rnf152* MO\
WISH analysis of *rnf152* MO using *deltaD* as a probe. (A, D) WT embryos, (B, E) embryos injected with 5′ mismatch as control, and (C, F) *rnf152* MO. *deltaD* transcripts were abundant in the ventral midbrain and rhombomeres of the brain but low in the eyes of WT (A, D) and 5′ mismatch (B, D). However, level of *deltaD* transcripts was significantly reduced in the respected tissues (C, F). Red arrowheads indicate the eye, midbrain, and hindbrain (n = 3). Scale bars (A--F): 50 μm.](molce-40-12-945f5){#f5-molce-40-12-945}

![Knock-down of *rnf152* down-regulated transcription of *notch1a* and *notch3*\
WISH analysis of *rnf152* MO using *notch1a* and *notch3* as probes. (A, D) *notch1a* transcripts in the eye, forebrain, midbrain, and hindbrain of WT embryos at 24 hpf. (B, E) Embryos injected with 5′ mismatch at 24 hpf showed similar patterns to those of WT embryos. (C, F) *rnf152* MO shows remarkable reduction of *notch1a* transcripts in the eyes, forebrain, midbrain, and hindbrain at 24 hpf. Eyes, mid-hindbrain were shown in red arrowheads. Transcripts of *notch3* in (I, L) *rnf152* MO, (G, J) WT, and (H, K) 5′ mismatch control at 24 hpf. *notch3* transcripts were present in the olfactory bulbs, midbrain, and hindbrain in WT and 5′ mismatch control whereas they were significantly diminished in the corresponding areas of *rnf152* MO. Red arrowheads indicate eyes, mid-hindbrain tissues (n = 3). Scale bars (A--L): 50 μm.](molce-40-12-945f6){#f6-molce-40-12-945}

![rnf152 knock-down reduced expression of *ascl1a* and *her4* in zebrafish embryos\
(A--F) Dorsal view of embryos at 29 hpf. WISH analysis with *her4* detected the transcripts in the eyes, forebrain, mid-hindbrain, and spinal cord of the WT (A) and 5′ mismatch control (B) while they disappeared in the eye and rhombomeres of *rnf152* MO (C). Red arrowheads indicate *her4* transcripts in the eyes and anterior rhombomeres (n = 3). WISH analysis with *ascl1a* found that *ascl1a* transcripts in the eyes, forebrain and mid-hindbrain of the two control groups but were significantly reduced in those of *rnf152* MO. Red arrowheads indicate the eyes and rhombomeres (n = 3). Abbreviations: fb- forebrain, mb- midbrain, hb- hindbrain, ret- retina. Scale bars (A--F): 50 μm.](molce-40-12-945f7){#f7-molce-40-12-945}
